FI67571C - Foerfarande foer framstaellning av ett nytt biologiskt aktivt aemne - Google Patents

Foerfarande foer framstaellning av ett nytt biologiskt aktivt aemne Download PDF

Info

Publication number
FI67571C
FI67571C FI801251A FI801251A FI67571C FI 67571 C FI67571 C FI 67571C FI 801251 A FI801251 A FI 801251A FI 801251 A FI801251 A FI 801251A FI 67571 C FI67571 C FI 67571C
Authority
FI
Finland
Prior art keywords
cells
substance
strain
micrococcus
liters
Prior art date
Application number
FI801251A
Other languages
English (en)
Finnish (fi)
Other versions
FI801251A (fi
FI67571B (fi
Inventor
Jean Florent
Jean Lunel
Nee Courtillet Denise Mancy
Bernard Vuillemin
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of FI801251A publication Critical patent/FI801251A/fi
Publication of FI67571B publication Critical patent/FI67571B/fi
Application granted granted Critical
Publication of FI67571C publication Critical patent/FI67571C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/265—Micrococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/859—Micrococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI801251A 1979-04-18 1980-04-18 Foerfarande foer framstaellning av ett nytt biologiskt aktivt aemne FI67571C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7909743 1979-04-18
FR7909743A FR2454302A1 (fr) 1979-04-18 1979-04-18 Nouvelle substance biologiquement active, sa preparation et les medicaments qui la contiennent

Publications (3)

Publication Number Publication Date
FI801251A FI801251A (fi) 1980-10-19
FI67571B FI67571B (fi) 1984-12-31
FI67571C true FI67571C (fi) 1985-04-10

Family

ID=9224428

Family Applications (1)

Application Number Title Priority Date Filing Date
FI801251A FI67571C (fi) 1979-04-18 1980-04-18 Foerfarande foer framstaellning av ett nytt biologiskt aktivt aemne

Country Status (26)

Country Link
US (1) US4313936A (pl)
JP (1) JPS5611795A (pl)
AT (1) AT370129B (pl)
AU (1) AU538492B2 (pl)
BE (1) BE882841A (pl)
CA (1) CA1122526A (pl)
CH (1) CH646873A5 (pl)
DE (1) DE3015030A1 (pl)
DK (1) DK163980A (pl)
ES (1) ES8200920A1 (pl)
FI (1) FI67571C (pl)
FR (1) FR2454302A1 (pl)
GB (1) GB2046759B (pl)
GR (1) GR66676B (pl)
HU (1) HU181104B (pl)
IE (1) IE49446B1 (pl)
IL (1) IL59842A (pl)
IT (1) IT1209323B (pl)
LU (1) LU82370A1 (pl)
NL (1) NL8002108A (pl)
NO (1) NO155103C (pl)
NZ (1) NZ193457A (pl)
PT (1) PT71107A (pl)
SE (1) SE446344B (pl)
SU (1) SU1042602A3 (pl)
ZA (1) ZA802271B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤
CH680192A5 (pl) * 1989-12-13 1992-07-15 Nestle Sa
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547388A (fr) * 1967-02-22 1968-11-29 Rhone Poulenc Sa Nouvel antibiotique et sa préparation par culture d'un streptomyces
US4174390A (en) * 1977-02-07 1979-11-13 Eli Lilly And Company Antibiotic A-7413 and process for preparation thereof
US4180565A (en) * 1978-05-25 1979-12-25 Schering Corporation 1-N-substituted derivatives of 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols

Also Published As

Publication number Publication date
IT1209323B (it) 1989-07-16
FR2454302A1 (fr) 1980-11-14
CA1122526A (fr) 1982-04-27
DE3015030A1 (de) 1981-05-07
AU5749480A (en) 1980-10-23
SU1042602A3 (ru) 1983-09-15
DK163980A (da) 1980-10-19
ZA802271B (en) 1981-04-29
NO155103B (no) 1986-11-03
NO155103C (no) 1987-02-11
JPS5611795A (en) 1981-02-05
ATA205480A (de) 1982-07-15
LU82370A1 (fr) 1980-12-16
HU181104B (en) 1983-06-28
SE8002898L (sv) 1980-10-19
AT370129B (de) 1983-03-10
GR66676B (pl) 1981-04-08
NO801114L (no) 1980-10-20
IE49446B1 (en) 1985-10-02
PT71107A (fr) 1980-05-01
NL8002108A (nl) 1980-10-21
ES490702A0 (es) 1981-11-16
BE882841A (fr) 1980-10-17
CH646873A5 (fr) 1984-12-28
JPS6251275B2 (pl) 1987-10-29
FI801251A (fi) 1980-10-19
FI67571B (fi) 1984-12-31
IL59842A0 (en) 1980-06-30
GB2046759A (en) 1980-11-19
ES8200920A1 (es) 1981-11-16
GB2046759B (en) 1983-02-23
FR2454302B1 (pl) 1982-05-21
IL59842A (en) 1984-02-29
NZ193457A (en) 1983-02-15
US4313936A (en) 1982-02-02
IE800772L (en) 1980-10-18
SE446344B (sv) 1986-09-01
DE3015030C2 (pl) 1988-09-08
IT8021495A0 (it) 1980-04-18
AU538492B2 (en) 1984-08-16

Similar Documents

Publication Publication Date Title
JPS6215560B2 (pl)
WO2010058427A2 (en) Process for production and purification of polymyxin b sulfate
EP0459367B1 (en) Method for preparing an antitumor dextran
FI67571C (fi) Foerfarande foer framstaellning av ett nytt biologiskt aktivt aemne
KR870001987B1 (ko) 엔듀라시딘의 제조방법
SE461532B (sv) Cancermotverkande och immunaktiverande aemne (spf-100)
KR830002535B1 (ko) 신규 생물학적 활성 물질의 제조방법
JPH022589B2 (pl)
US4824945A (en) Hypocholesterolemically active RNA fractions
JP3107455B2 (ja) 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JP2936663B2 (ja) Ｆｒ９０１２２８物質の製造方法
EP0131456A2 (en) Production of vitamin B12 employing a fused cell hybrid
RU2113477C1 (ru) Штамм kluyveromyces marxianus var. bulgaricus t3 - продуцент супероксид дисмутазы и сопутствующих ферментов
RU2089215C1 (ru) Способ получения менингококкового серогруппы в липоолигосахарида
EP0024206A2 (en) Antitumor substance, composition comprising it and process for preparing said substance
US5177007A (en) Process for producing optically active r-(+)-2,3-dichloro-1-propanol using microorganism
JPH0378998B2 (pl)
JPH0144721B2 (pl)
JPH0342070B2 (pl)
EP0091745A1 (en) Preparation of an antibiotic selectively effective against staphylococcus infections
JPH04267886A (ja) βーグルコオリゴ糖の製造方法
EP0142121A2 (en) WS 7739 substances, their preparation and pharmaceutical composition containing the same
JPS61199797A (ja) 新規化合物アデクロリンおよびその製造法
JPS58180426A (ja) 抗腫瘍性物質
JPH0370719B2 (pl)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RHONE- POULENC INDUSTRIES